Biotechnology - Genomic and Proteomics/Open Business models in BGP: Difference between revisions

From Commons Based Research
Jump to navigation Jump to search
Line 1: Line 1:
[[Report April 2009]]
[[Report April 2009]]
==Answer==
==Data==
 
==Narratives==
 
Open Access Business Models [[KEI study]]
 
==Tools==
 
==back==
* TDI “A kernel for the Tropical Disease Initiative”, Leticia Ort’ et. al., Nature Publishing Group,  
* TDI “A kernel for the Tropical Disease Initiative”, Leticia Ort’ et. al., Nature Publishing Group,  
** Problem it aims to address: open source drug development has not been successful because there lacks a critical mass of publicly available data. Focus on tropical diseases
** Problem it aims to address: open source drug development has not been successful because there lacks a critical mass of publicly available data. Focus on tropical diseases

Revision as of 13:14, 9 November 2009

Report April 2009

Data

Narratives

Open Access Business Models KEI study

Tools

back

  • TDI “A kernel for the Tropical Disease Initiative”, Leticia Ort’ et. al., Nature Publishing Group,

Navigation

Bibliography for Item 12 in BGP
Biotechnology_-_Genomic_and_Proteomics